GoodRx (GDRX)
(Delayed Data from NSDQ)
$8.74 USD
-0.23 (-2.56%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $8.64 -0.10 (-1.14%) 6:42 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
GoodRx Holdings, Inc. [GDRX]
Reports for Purchase
Showing records 1 - 20 ( 108 total )
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Investor Meeting Takeaways: Pivoting Into Opportunities in 2024
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Optimized Entry and Exit Levels for GDRX 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Repurchasing ~$65.6M of Stock from Spectrum Asset Management Following CEO Scott Wagner''s Recent ~$677K Open Market Stock Purchase
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Company: GoodRx Holdings, Inc.
Industry: Medical Services
3Q Bottom-Line Beat; FY Profit Guidance Raised
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: GoodRx Holdings, Inc.
Industry: Medical Services
Lowering Estimates on FY24 Initial Guide; Await Clarity and Execution Heading into Next Year
Provider: KeyBanc Capital Markets
Analyst: Research Department